News

›
25
COMMENTARY ON PUBLICATIONS – ANSWER TO A QUESTION FROM THE CAPITAL MARKET COMMITTEE The company with the name “ATHENS MEDICAL COMMERCIAL SOCIETY ANONYME” (hereinafter the “Company”), informs the investing public of the following: Regarding today’s publications that appeared in the electronic press and refer to an alleged agreement for the acquisition of the Company by a foreign fund and/or an imminent public offer for exit from Euronext Athens, the Company, following information received from its main shareholders, declares that the said publications are untrue and have absolutely no basis. The...
16
ECONOMIC CALENDAR 2026 “ATHENS MEDICAL COMMERCIAL SOCIETE ANONYME” (the “Company”) announces the Financial Calendar for the year 2026, in accordance with articles 4.1.2. of section 4 of the Athens Stock Exchange Regulation and Decision 25 of the Stock Exchange Markets Management Committee of the Athens Stock Exchange, as follows: Announcement of Results for the Year 2025: Thursday, April 30, 2026 Annual update to analysts: Friday, June 19, 2026 Annual Ordinary General Meeting of Shareholders: Friday, June 26, 2026 Announcement of Results for the Half-Year 2026: We...
02
Notification of change in the composition of the Board of Directors. “ATHENS MEDICAL COMMERCIAL SOCIETE ANONYME” (hereinafter the “Company”) informs the investing public, in accordance with par. 4.1.1. para. 22 of the Athens Stock Exchange Regulation, that the Board of Directors of the Company, at its meeting on January 2, 2026, following the resignation of Dr. Georgios Apostolopoulos from the position of Chairman and his expressed intention to transfer the daily management and strategic development of the Group to his two sons, Vasilis and Christos Apostolopoulos, who jointly assume t...
24
Announcement of comments on publications “ATHENS MEDICAL COMMERCIAL SOCIETY ANONYME” (hereinafter the “Company”), in accordance with the applicable legislative framework, and with regard to the publication of the Mononews website of 23/12/2025, entitled: “Change of guard after 41 years at Athens Medical”, informs the investing public that this publication reflects the expressed intention of its President Dr. Georgios Apostolopoulos. These changes will be effective from January 2, 2026 following the official approval process by the Board of Directors and its new constitution. The Co...
03
Announcement of change in senior management – ​​new Chief Financial Officer Notification of change in senior management – ​​new Chief Financial Officer “ATHENS MEDICAL CENTER S.A. COMMERCIAL SOCIETE ANONYME” (hereinafter referred to as the “Company”) hereby informs investors that Mr. Emmanuel Markopoulos has resigned (due to retirement) from the position of Chief Financial Officer. His duties are being assumed by the Chief Financial Officer of the Athens Medical Group, Ms. Marina Mazaraki. The Company thanks Mr. Emmanuel Markopoulos for his many years of contribution and cooperation. Notification of change in senior...
29
SPECIAL ANNUAL REPORT SEPTEMBER 2025 SPECIAL ANNUAL REPORT According to the provision of par. 1 of article 3C of Law 4706/2020 as amended by Law 5193/2025 COMPANY DETAILS Name: ATHENS MEDICAL COMMERCIAL SOCIETE ANONYME GEMI Number: 000356301000 VAT Number: 094129169 Sector of activity: Provision of health services Number of employees at individual level: 3,495 people Annual turnover (2024): € 265,633 thousand Annual Company Balance Sheet: (assets) 505,253 thousand   GENDER REPRESENTATION DATA ON THE BOARD OF DIRECTORS TOTAL MEMBERS MALE MEMBERS FEMALE MEMBERS PERCENTAGE OF...
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.